Analogues of Natural Macarangin B Display Potent Antiviral Activity and Better Metabolic Stability
ChemMedChem · 2025
DOI: 10.1002/cmdc.202400978 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Gwenaëlle Jézéquel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Chimie des Substances Naturelles, Université Paris-Saclay, CNRS, 91198, Gif-sur-Yvette, France. Hauptthemen laut MEDLINE: Antiviral Agents, Zika Virus, Biological Products. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: SATT Paris-Saclay, Université Paris Saclay, French government.
Abstract (Originalsprache)
The development of innovative antiviral strategies is critical to address the global health threats posed by RNA viruses, including the Zika virus (ZIKV), which can cause severe neurological complications. The lipid transporter Oxysterol Binding Protein (OSBP), essential for cholesterol and phosphatidylinositol 4‐phosphate trafficking, is exploited by many positive‐strand RNA viruses, making it an attractive novel antiviral target. This study investigates simplified analogues of macarangin B, a natural compound with potent OSBP‐targeted antiviral activity against ZIKV, but limited stability due to its flavonol moiety. A series of analogues was synthesized, replacing the flavonol with a flavone core while retaining the essential hexahydroxanthene (HHX) motif. These compounds demonstrated improved stability (t 1/2 =16 hours), high OSBP binding affinity (4 – 69 nM), and low cytotoxicity (>20 μM). The most active compounds exhibited antiviral activity comparable to established OSBP inhibitors and were stable in physiologic media, highlighting their potential as leads for therapeutic development. This work advances the structure‐activity relationship (SAR) understanding of macarangin B analogues and provides a foundation for designing effective antivirals targeting in ZIKV infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut de Chimie des Substances Naturelles, Université Paris-Saclay, CNRS, 91198, Gif-sur-Yvette, France.
- Institut de Pharmacologie Moléculaire et Cellulaire, Université Côte d'Azur, Inserm, CNRS, 06560, Valbonne, France.
- Unité Mixte Processus Infectieux en Milieu Insulaire Tropical, Plateforme Technologique CYROI, Université de la Réunion, Inserm, CNRS, IRD, 94791, Sainte Clotilde, France.
- Present address: Institut Curie, Université PSL, CNRS UMR9187, Inserm U1196, 91400, Orsay, France.
- Université Paris-Saclay, CNRS UMR9187, Inserm U1196, 91400, Orsay, France.
ORCID-Profile: Gwenaëlle Jézéquel, Joëlle Bigay, Chaker El Kalamouni, Sandy Desrat, Fanny Roussi
Förderung
- SATT Paris-Saclay
- Université Paris Saclay
- French government
- ANRS I MIE
- INSERM
Zitieren
APA
Jézéquel, G., Fargier, J., Bigay, J., Polidori, J., Geslin, J., Hue, N., El Kalamouni, C., Desrat, S., & Roussi, F. (2025). Analogues of Natural Macarangin B Display Potent Antiviral Activity and Better Metabolic Stability. ChemMedChem. https://doi.org/10.1002/cmdc.202400978
Vancouver
Jézéquel G, Fargier J, Bigay J, Polidori J, Geslin J, Hue N, et al. Analogues of Natural Macarangin B Display Potent Antiviral Activity and Better Metabolic Stability. ChemMedChem. 2025. doi:10.1002/cmdc.202400978
BibTeX
@article{Jzquel2025,
author = {Jézéquel, Gwenaëlle and Fargier, Jules and Bigay, Joëlle and Polidori, Joël and Geslin, Justine and Hue, Nathalie and El Kalamouni, Chaker and Desrat, Sandy and Roussi, Fanny},
title = {Analogues of Natural Macarangin B Display Potent Antiviral Activity and Better Metabolic Stability},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202400978}
}
EUVIMED